Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Notes Payables: 2023

Historic Notes Payables for Biofrontera (BFRI) over the last 1 years, with Dec 2023 value amounting to $3.9 million.

  • Biofrontera's Notes Payables was N/A to $296,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $296,000, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2023, which is N/A change from last year.
  • Per Biofrontera's latest filing, its Notes Payables stood at $3.9 million for FY2023.
  • Over the past 5 years, Biofrontera's Notes Payables peaked at $3.9 million during FY2023, and registered a low of $3.9 million during FY2023.
  • Its 1-year average for Notes Payables is $3.9 million, with a median of $3.9 million in 2023.